GoodRx Partners with Viatris to Provide Up to 85% Savings on Brand Medications
GoodRx Partners with Viatris to Offer Up to 85% Savings on Established Brand Medications GoodRx the leading platform for prescription savings in the U.S., announced a new collaboration with Viatris, a global healthcare company, to make 17 of its established…
Planet DDS 2026 Dental Outlook Reports More New Patients and Fewer No-Shows Across the Industry
Planet DDS 2026 Dental Outlook Shows More New Patients, Fewer No-Shows Across the Industry Planet DDS, a leading provider of cloud-based, enterprise-grade dental software solutions, announced the release of its 2026 Dental Industry Outlook, an annual benchmark report designed to help…
GeneDx Exome & Genome Testing Linked to $80K Savings and Better Outcomes
GeneDx Study Shows Significant Healthcare Cost Savings and Improved Outcomes for Children After Genomic Testing A new real-world data study presented by GeneDx has revealed that genomic testing can dramatically reduce healthcare costs and improve clinical outcomes for children with…
InterSystems Appoints Tim Ferris as Vice President of Healthcare Practice
InterSystems Appoints Tim Ferris as Vice President of Healthcare Practice InterSystems, a global data technology company that supports more than one billion health records worldwide, has announced the appointment of Tim Ferris as Vice President of its Healthcare Practice. The…
C2N Diagnostics Expands to South Korea with BeauBrain Partnership for Precivity™ Tests
C2N Diagnostics Enters South Korean Market Through Partnership with BeauBrain Healthcare to Offer Precivity™ Portfolio of Blood Tests for Alzheimer’s Diagnosis Specialty diagnostics company C2N Diagnostics has announced a strategic partnership with South Korea–based healthcare firm BeauBrain Healthcare to introduce…
United Therapeutics Corporation Publishes TETON-2 Phase 3 Trial Results
United Therapeutics Corporation Shares TETON-2 Phase 3 Trial Findings in The New England Journal of Medicine United Therapeutics Corporation announced that the complete findings from its Phase 3 TETON-2 clinical trial evaluating nebulized Tyvaso® (treprostinil) inhalation solution for the treatment…
Precision BioSciences Secures U.S. Patent Allowances for PBGENE-HBV Program
Precision BioSciences Receives U.S. Patent Allowances Covering the PBGENE-HBV Program Precision BioSciences, Inc. a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today announced that it has received…
Parabilis Medicines’ Zolucatetide Receives FDA Orphan Drug Designation for Desmoid Tumor Treatment
Parabilis Medicines’ Zolucatetide, the First and Only Direct Inhibitor of the Elusive β-catenin:TCF Interaction, Receives FDA Orphan Drug Designation for the Treatment of Desmoid Tumors Parabilis Medicines, a clinical-stage biopharmaceutical company committed to creating extraordinary medicines for people living with…
Eurofins Biomnis Launches Advanced LC-MS/MS Test for Cereulide Toxin Detection in Stool
Eurofins Biomnis Launches New Clinical LC‑MS/MS Method for the Detection of Cereulide Toxin in Stool Samples Eurofins Biomnis, a leading European provider of specialised clinical diagnostics services, and part of the global network of Eurofins laboratories, announces the successful development…
Curatis Grants Neupharma Exclusive Japan Rights for Corticorelin (C-PTBE-01)
Curatis and Neupharma Announce Exclusive Licensing Agreement to Develop and Market Corticorelin (C-PTBE-01) for the Treatment of Peritumoral Brain Edema in Japan Curatis Holding AG and Neupharma Co., Ltd. a Japanese pharmaceutical company specializing in oncology, immunology, pulmonology and cardiology…
Lyra Health Named Preferred Mental Health Partner for Workday Wellness
Lyra Health Joins Workday Wellness Program as Preferred Mental Health Partner Lyra Health, the leader in workforce mental health solutions, announced that it has been named the Workday Wellness Preferred Mental Health Partner. This designation recognizes Lyra’s extensive experience in…
GeneDx Launches Genetic Testing Program with Zevra Therapeutics
GeneDx to Launch Genetic Testing Program with Zevra Therapeutics to Support Patients with Suspected Niemann-Pick Disease Type C GeneDx the leader in rare disease diagnosis and improving health through the power of genomic data, announced a new genetic testing program…